Sudair Pharma CEO Featured on Saudi TV’s “AlMashroa” Program
Sudair Pharma CEO, Dr. Yasser Alobaidaa, appeared on Saudi TV’s “AlMashroa” program to discuss the company’s strategic direction, national ambitions, and the role of local pharmaceutical manufacturing in supporting Saudi Arabia’s healthcare future.
Sudair Pharma Recognized by the Local Content and Government Procurement Authority During Executive Visit
Sudair Pharma welcomed the CEO of the Local Content and Government Procurement Authority (LCGPA) in a visit during which the company was honored as a strategic national partner for its active role in strengthening local content and contributing to the national economy.
Sudair Pharma Signs Collaboration Agreement with University of Hafr Al-Batin to Develop Pharmaceutical Talent
Sudair Pharma signed a cooperation agreement with the University of Hafr Al-Batin to support student skill development, enhance academic-industrial collaboration, and promote shared goals aligned with Saudi Vision 2030.
Local Content and Government Procurement Authority Highlights Sudair Pharma’s Achievements in Healthcare Localization
The Local Content and Government Procurement Authority highlighted Sudair Pharma’s achievements as a strategic partner in advancing healthcare localization and supporting national self-sufficiency through impactful industrial and operational initiatives.
Sudair Pharma Showcases Innovative Pharmaceutical Solutions at CPHI Milan 2024
Sudair Pharma participated in CPHI Milan 2024 as part of the Saudi Made pavilion, showcasing advanced pharmaceutical solutions and reaffirming its commitment to innovation and localization in the Kingdom’s healthcare sector.
Sudair Pharma Participates in National Agreement with Sanofi and NUPCO to Localize Insulin Production in Saudi Arabia
Sudair Pharma is proud to be part of a national agreement with Sanofi and NUPCO to localize insulin production in Saudi Arabia, supporting pharmaceutical security and strengthening the Kingdom’s position as a regional center for healthcare innovation.
Sudair Pharma Highlighted in the National Local Content Report for Its Advancements in Pharmaceutical Localization
Sudair Pharma was featured in the sixth edition of the National Local Content Report, highlighting its progress in localizing pharmaceutical products and contributing to national economic development.
Sudair Pharma Showcases Major Local Content Achievements at the Local Content Forum 2024
Sudair Pharma participated prominently in the Local Content Forum 2024, announcing the launch of its “Ghrs Program” for local content development, showcasing strategic achievements, and taking part in key panel discussions, workshops, and exhibitions. The company reaffirmed its commitment to strengthening national pharmaceutical security and advancing local innovation in alignment with Saudi Vision 2030.
Sudair Pharma Achieves “Saudi Made” Golden Tier Classification
Sudair Pharma has been awarded the prestigious Saudi Made Golden Tier classification, recognizing the company’s exceptional contribution to national localization efforts, investment in Saudi talent, and utilization of locally sourced materials in pharmaceutical manufacturing.
Saudi Minister of Health Visits Sudair Pharma to Review Advanced Pharmaceutical Facilities and Strengthen National Drug Security
Sudair Pharma welcomed His Excellency the Minister of Health for an official visit to review the company’s advanced manufacturing facilities and pharmaceutical technologies. The visit also included a symbolic palm-tree planting ceremony and highlighted Sudair Pharma’s pivotal role in strengthening national drug security and supporting Vision 2030 objectives.